GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » Total Assets

Xlife Sciences AG (CHIX:XLSZ) Total Assets : CHF509.86 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Xlife Sciences AG Total Assets?

Xlife Sciences AG's Total Assets for the quarter that ended in Jun. 2024 was CHF509.86 Mil.

During the past 12 months, Xlife Sciences AG's average Total Assets Growth Rate was 6.80% per year. During the past 3 years, the average Total Assets Growth Rate was 41.40% per year. During the past 5 years, the average Total Assets Growth Rate was 36.50% per year.

During the past 6 years, Xlife Sciences AG's highest 3-Year average Total Assets Growth Rate was 49.80%. The lowest was 41.40%. And the median was 47.90%.

Total Assets is connected with ROA %. Xlife Sciences AG's annualized ROA % for the quarter that ended in Jun. 2024 was 0.19%. Total Assets is also linked to Revenue through Asset Turnover. Xlife Sciences AG's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Xlife Sciences AG Total Assets Historical Data

The historical data trend for Xlife Sciences AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Total Assets Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 154.02 185.68 480.06 490.23 511.99

Xlife Sciences AG Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 470.82 490.23 477.94 511.99 509.86

Xlife Sciences AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Xlife Sciences AG's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=365.037+146.957
=511.99

Xlife Sciences AG's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (Q: Jun. 2024 )+Total Liabilities (Q: Jun. 2024 )
=366.979+142.883
=509.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xlife Sciences AG  (CHIX:XLSz) Total Assets Explanation

Total Assets is connected with ROA %.

Xlife Sciences AG's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0.946/( (511.994+509.862)/ 2 )
=0.946/510.928
=0.19 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Xlife Sciences AG's Asset Turnover for the quarter that ended in Jun. 2024 is

Asset Turnover
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0.35/( (511.994+509.862)/ 2 )
=0.35/510.928
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Xlife Sciences AG Total Assets Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » Total Assets
Comparable Companies
XSWX:MOLN XSWX:NWRN XSWX:SANN XSWX:IDIA XSWX:BIOV XSWX:RLF XSWX:EVE XSWX:ADXN XSWX:BSLN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT
Traded in Other Exchanges
XLS:Switzerland
Address
Talacker 35, Zurich, CHE, 8001
Website
https://www.xlifesciences.ch
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.

Xlife Sciences AG Headlines

No Headlines